Abstract:Introduction: Preeclampsia is a pregnancy-specific disorder characterized by de novo development of hypertension and proteinuria over 20 weeks gestation that has been associated with the dysfunction of trophoblasts. Current evidence suggests that syncytin-1 plays an important role in the non-fusogenic biological activity of trophoblasts, except for specific fusogenic function. However, the underlying mechanism remains unclear. Methods: The expression and location of syncytin-1 in normal and the late-onset preeclampsia placentas were detected by quantitative real-time PCR, western blotting and immunofluorescence. Morphological and apoptosis analysis were processed in placentas. The ex vivo extravillous explant culture model was used to explore the effect of syncytin-1 on EVT outgrowths. Real-time quantitative PCR and immunoblotting were used to calculate syncytin-1 levels in the trophoblast cells before and after syncytin-1 knockdown or overexpression. CCK-8 assay was used to detect the cell viability. TUNEL staining and immunoblotting were processed in trophoblast cells. Transwell assays and wound healing assays were utilize to assess the invasion and migration of trophoblastic cells. Conditional knockout of syncytin-a mouse model was conducted to present the change of placentas in vivo. The ex vivo extravillous explant culture model was used to explore the effect of syncytin-1 on EVT outgrowths. Western blotting was used to identify the key proteins of PI3K/Akt pathways and invasion-related proteins in trophoblast cells. Results and discussion: Here, reduced syncytin-1 was identified in the late-onset preeclampsia placentas. Reduced syncytin-1 may attenuates the EMT process by promoting apoptosis, inhibiting proliferation and invasion by suppressed PI3K/Akt pathway in trophoblast cells. Our findings provide novel insights into the non-fusogenic biological function of reduced syncytin-1 that may be involves in the pathogenesis of preeclampsia.

Syncytin-1 modulates placental trophoblast cell proliferation by promoting G1/S transition.

Fine-Tuned and Cell-Cycle-Restricted Expression of Fusogenic Protein Syncytin-2 Maintains Functional Placental Syncytia

Syncytin and Fusion of Trophoblast

Epigenetic and non-epigenetic regulation of syncytin-1 expression in human placenta and cancer tissues

Inducible knockout of syncytin-a leads to poor placental glucose transport in mice

Altered Syncytin and ASCT2 Expressions in Preeclampsic Placenta and Hypoxia-Treated BeWo Cells Syncytialization

Reduced syncytin-1 regulates trophoblast invasion and apoptosis in preeclampsia

Syncytin-A Mediates the Formation of Syncytiotrophoblast Involved in Mouse Placental Development

Decreased Expression and Altered Methylation of Syncytin-1 Gene in Human Placentas Associated with Preeclampsia

Reduced Syncytin-1 Expression in Choriocarcinoma BeWo Cells Activates the Calpain1–aif-Mediated Apoptosis, Implication for Preeclampsia

Epigenetic drug screening for trophoblast syncytialization reveals a novel role for MLL1 in regulating fetoplacental growth

Appropriate expression of P57<SUP>kip2</SUP> drives trophoblast fusion via cell cycle arrest

TFEB controls syncytiotrophoblast differentiation

NPFF Increases Fusogenic Proteins Syncytin 1 and Syncytin 2 Via GCM1 in First Trimester Primary Human Cytotrophoblast Cells.

Placental trophoblast syncytialization potentiates macropinocytosis via mTOR signaling to adapt to reduced amino acid supply

Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor

Effects of individually silenced N-glycosylation sites and non-synonymous single-nucleotide polymorphisms on the fusogenic function of human syncytin-2

TFEB controls expression of human syncytins during cell-cell fusion

Declined placental PLAC1 expression is involved in preeclampsia.

Placental cytotrophoblast microvillar stabilization is required for cell-cell fusion

THBS1 regulates trophoblast fusion through a CD36-dependent inhibition of cAMP, and its upregulation participates in preeclampsia